Connection

Francesco Annunziato to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Francesco Annunziato has written about Treatment Outcome.
Francesco Annunziato
Connection Strength
0.016
Treatment Outcome
  1. Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab. Immunol Lett. 2020 12; 228:122-128.
    View in: PubMed
    Score: 0.008
  2. Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study. Leukemia. 2021 04; 35(4):1121-1133.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.